Avicine: Completed Phase II trial enrollment

AVI BioPharma Inc. (AVII), Portland, Ore. Product: Avicine Business: Cancer Therapeutic category: Immune stimulation Target: Immune cells Description: Synthetic peptide vaccine against human chorioni...